These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 4352254)

  • 21. [Reactivation of herpes zoster infection by varicella-zoster virus].
    Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M
    Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.
    Wrensch M; Weinberg A; Wiencke J; Miike R; Sison J; Wiemels J; Barger G; DeLorenze G; Aldape K; Kelsey K
    Am J Epidemiol; 2005 May; 161(10):929-38. PubMed ID: 15870157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS.
    HOPE-SIMPSON RE
    Proc R Soc Med; 1965 Jan; 58(1):9-20. PubMed ID: 14267505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of certain infectious diseases on tuberculin allergy.
    BENTZON JW
    Tubercle; 1953 Feb; 34(2):34-41. PubMed ID: 13029161
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term cyclophosphamide therapy in rheumatoid arthritis.
    Fosdick WM; Parsons JL; Hill DF
    Arthritis Rheum; 1968 Apr; 11(2):151-61. PubMed ID: 5650792
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of measles immunization on tuberculin hypersensitivity and in vitro lymphocyte reactivity.
    Zweiman B; Pappagianis D; Maibach H; Hildreth EA
    Int Arch Allergy Appl Immunol; 1971; 40(6):834-41. PubMed ID: 5562588
    [No Abstract]   [Full Text] [Related]  

  • 27. Long survival in Hodgkin's disease.
    Chawla PL; Stutzman L; Dubois RE; Kim U; Sokal JE
    Am J Med; 1970 Jan; 48(1):85-92. PubMed ID: 5415408
    [No Abstract]   [Full Text] [Related]  

  • 28. The activation of varicella-zoster virus infections by immunosuppressive therapy.
    Rifkind D
    J Lab Clin Med; 1966 Sep; 68(3):463-74. PubMed ID: 5332136
    [No Abstract]   [Full Text] [Related]  

  • 29. Viral infections in man associated with acquired immunological deficiency states.
    Merigan TC; Stevens DA
    Fed Proc; 1971; 30(6):1858-64. PubMed ID: 4333313
    [No Abstract]   [Full Text] [Related]  

  • 30. Varicella-Zoster infection in patients with cancer.
    Schimpff S; Serpick A; Stoler B; Rumack B; Mellin H; Joseph JM; Block J
    Ann Intern Med; 1972 Feb; 76(2):241-54. PubMed ID: 4333228
    [No Abstract]   [Full Text] [Related]  

  • 31. Herpes Zoster-Varicella infections and lymphoma.
    Goffinet DR; Glatstein EJ; Merigan TC
    Ann Intern Med; 1972 Feb; 76(2):235-40. PubMed ID: 4333227
    [No Abstract]   [Full Text] [Related]  

  • 32. Laboratory studies on the varicella-zoster virus.
    Meurisse EV
    J Med Microbiol; 1969 Aug; 2(3):317-25. PubMed ID: 4325755
    [No Abstract]   [Full Text] [Related]  

  • 33. Recurrent viral infection (reinfection).
    Chang TW
    N Engl J Med; 1971 Apr; 284(14):765-73. PubMed ID: 4323312
    [No Abstract]   [Full Text] [Related]  

  • 34. Zoster, reinfection or activation of latent virus? Observations on the antibody response.
    Miller LH; Brunell PA
    Am J Med; 1970 Oct; 49(4):480-3. PubMed ID: 4320119
    [No Abstract]   [Full Text] [Related]  

  • 35. Cutaneous interferon production in patients with Hodgkin's disease and other cancers infected with varicella or vaccinia.
    Armstrong RW; Gurwith MJ; Waddell D; Merigan TC
    N Engl J Med; 1970 Nov; 283(22):1182-7. PubMed ID: 4319626
    [No Abstract]   [Full Text] [Related]  

  • 36. Characteristics of herpes zoster and varicella viruses propagated in vitro.
    Gold E
    J Immunol; 1965 Oct; 95(4):683-91. PubMed ID: 4284677
    [No Abstract]   [Full Text] [Related]  

  • 37. An immunological approach to ageing.
    Burnet FM
    Lancet; 1970 Aug; 2(7668):358-60. PubMed ID: 4194454
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of varicella by zoster immune globulin.
    Brunell PA; Ross A; Miller LH; Kuo B
    N Engl J Med; 1969 May; 280(22):1191-4. PubMed ID: 4181206
    [No Abstract]   [Full Text] [Related]  

  • 39. Exogenous or endogenous causation of shingles.
    Taylor-Robinson D; Slack PM
    Lancet; 1972 Jan; 1(7742):151. PubMed ID: 4109010
    [No Abstract]   [Full Text] [Related]  

  • 40. Cell-mediated immunity to Varicella-Zoster antigen in acute Herpes zoster (shingles).
    Russell AS; Maini RA; Bailey M; Dumonde DC
    Clin Exp Immunol; 1973 Jun; 14(2):181-5. PubMed ID: 4352254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.